Obesity and the Risk of Cryptogenic Ischemic Stroke in Young Adults.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
May 2022
Historique:
received: 10 11 2021
revised: 31 12 2021
accepted: 29 01 2022
pubmed: 23 2 2022
medline: 19 4 2022
entrez: 22 2 2022
Statut: ppublish

Résumé

We examined the association between obesity and early-onset cryptogenic ischemic stroke (CIS) and whether fat distribution or sex altered this association. This prospective, multi-center, case-control study included 345 patients, aged 18-49 years, with first-ever, acute CIS. The control group included 345 age- and sex-matched stroke-free individuals. We measured height, weight, waist circumference, and hip circumference. Obesity metrics analyzed included body mass index (BMI), waist-to-hip ratio (WHR), waist-to-stature ratio (WSR), and a body shape index (ABSI). Models were adjusted for age, level of education, vascular risk factors, and migraine with aura. After adjusting for demographics, vascular risk factors, and migraine with aura, the highest tertile of WHR was associated with CIS (OR for highest versus lowest WHR tertile 2.81, 95%CI 1.43-5.51; P=0.003). In sex-specific analyses, WHR tertiles were not associated with CIS. However, using WHO WHR cutoff values (>0.85 for women, >0.90 for men), abdominally obese women were at increased risk of CIS (OR 2.09, 95%CI 1.02-4.27; P=0.045). After adjusting for confounders, WC, BMI, WSR, or ABSI were not associated with CIS. Abdominal obesity measured with WHR was an independent risk factor for CIS in young adults after rigorous adjustment for concomitant risk factors.

Identifiants

pubmed: 35193029
pii: S1052-3057(22)00077-5
doi: 10.1016/j.jstrokecerebrovasdis.2022.106380
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106380

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflicts of interest.

Auteurs

Nina Jaakonmäki (N)

Kuopio University Hospital, Neurocenter Neurology, Finland and University of Eastern Finland, Kuopio University Hospital, P.O.B 100, FI-70029 KYS, Finland. Electronic address: ninajaa@student.uef.fi.

Marialuisa Zedde (M)

Neurology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Tomi Sarkanen (T)

Department of Neurology, Tampere University Hospital, Tampere, Finland and Faculty of Medicine and Health Technology, Tampere University, Finland.

Nicolas Martinez-Majander (N)

Neurology, Helsinki University Hospital, and University of Helsinki, Finland.

Suvi Tuohinen (S)

Cardiology, Helsinki University Hospital and University of Helsinki.

Juha Sinisalo (J)

Cardiology, Helsinki University Hospital and University of Helsinki.

Essi Ryödi (E)

Tampere Heart Hospital, Tampere, Finland.

Jaana Autere (J)

Kuopio University Hospital, Neurocenter Neurology, Finland and University of Eastern Finland, Kuopio University Hospital, P.O.B 100, FI-70029 KYS, Finland.

Marja Hedman (M)

Kuopio University Hospital Heart Center.

Ulla Junttola (U)

Clinical Neuroscience Research Unit and Department of Neurology, Oulu University Hospital, Finland.

Jaana K Huhtakangas (JK)

Clinical Neuroscience Research Unit, Oulu University Hospital, Finland.

Teresa Grimaldi (T)

Cardiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Rosario Pascarella (R)

Neuroradiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Annika Nordanstig (A)

Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sweden.

Odd Bech-Hanssen (O)

Department of Clinical Physiology, Institute of Medicine, the Sahlgrenska Academy, University of Gothernburg.

Christine Holbe (C)

Department of Neurology, University Medicine Greifswald, Greifswald, Germany.

Raila Busch (R)

Department of Internal Medicine B (Cardiology), University Medicine Greifswald, Greifswald, Germany.

Annette Fromm (A)

Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Pauli Ylikotila (P)

Department of Neurology, Neurocenter, Turku University Hospital, University of Turku, Finland.

Esme Ekizoglu Turgut (EE)

Istanbul Faculty of Medicine, Department of Neurology, Istanbul University, Turkey.

Isabel Amorim (I)

epartment of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria-CHLN, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Kristina Ryliskiene (K)

Vilnius University, Centre of Neurology, Lithuania.

Lauri Tulkki (L)

Neurology, Helsinki University Hospital, and University of Helsinki, Finland.

Laura Amaya Pascasio (LA)

Stroke Centre, Department of Neurology, Torrecádenas University Hospital. Health Research Centre, University of Almería, Almería, Spain.

Radim Licenik (R)

Peterborough City Hospital, UK.

Phillip Ferdinand (P)

Royal Stoke University Hospital, UK.

Georgios Tsivgoulis (G)

Second Department of Neurology, Attikon Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.

Dalius Jatužis (D)

Vilnius University, Centre of Neurology, Lithuania.

Liisa Kõrv (L)

Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.

Janika Kõrv (J)

Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.

Alessandro Pezzini (A)

Department of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Italy.

Ana Catarina Fonseca (AC)

epartment of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria-CHLN, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Nilufer Yesilot (N)

Istanbul Faculty of Medicine, Department of Neurology, Istanbul University, Turkey.

Risto O Roine (RO)

Department of Neurology, Neurocenter, Turku University Hospital, University of Turku, Finland.

Ulrike Waje-Andreassen (U)

Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Bettina von Sarnowski (B)

Department of Neurology, University Medicine Greifswald, Greifswald, Germany.

Petra Redfors (P)

Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sweden.

Juha Huhtakangas (J)

Clinical Neuroscience Research Unit and Department of Neurology, Oulu University Hospital, Finland.

Heikki Numminen (H)

Department of Neurology, Tampere University Hospital, Tampere, Finland and Faculty of Medicine and Health Technology, Tampere University, Finland.

Pekka Jäkälä (P)

Kuopio University Hospital, Neurocenter Neurology, Finland and University of Eastern Finland, Kuopio University Hospital, P.O.B 100, FI-70029 KYS, Finland.

Jukka Putaala (J)

Neurology, Helsinki University Hospital, and University of Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH